This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Atrial Fibrillation Heart Failure Hypertension 
Heart BMJ
MARCH 26, 2025
Heart failure (HF) is one of the significant complications in patients with myocardial infarction (MI), leading to increased risk for cardiovascular morbidity and mortality. Common predictors include older age, prior hypertension, diabetes and atrial fibrillation. HFrEF is more commonly.
Heart BMJ
DECEMBER 23, 2024
Current guideline indications for intervention in asymptomatic patient are centred on left ventricular dimensions and ejection fraction and may include consideration in atrial fibrillation, pulmonary hypertension and those with left atrial dilatation.
DAIC
JUNE 4, 2024
American College of Cardiology (ACC) and American Heart Association (AHA) Issue New Hypertrophic Cardiomyopathy (HCM) Management Guidelines 2. New Study Published in JACC: Heart Failure Reveals that Despite Significant Efforts to Improve Acute Heart Failure Treatment Over the Past 20 Years, Management Remains Unchanged 3.
Heart BMJ
OCTOBER 10, 2024
The term ‘epidemic’ is increasingly used to describe the rising global prevalence of atrial fibrillation (AF). The association between AF and various conditions—including hypertension, heart failure, sleep apnoea and chronic kidney disease—is well-described, highlighting that AF is often a multisystem disorder.
Frontiers in Cardiovascular Medicine
NOVEMBER 17, 2024
BackgroundAnemia is a common complication in patients with heart failure and is associated with left ventricular systolic dysfunction.
European Journal of Heart Failure
FEBRUARY 5, 2025
Methods and results TRED-HF was a randomized trial investigating heart failure therapy withdrawal in patients with recovered DCM over 6months. The primary outcome was relapse defined as 10% reduction in left ventricular ejection fraction to 400ng/L, or clinical features of heart failure.
The New England Journal of Medicine
JANUARY 24, 2024
This article reviews the use of digital wearable technologies for monitoring of three common cardiovascular conditions: hypertension, heart failure, and atrial fibrillation.
72 
HeartRhythm
SEPTEMBER 4, 2024
Heart failure with preserved ejection fraction (HFpEF) and atrial fibrillation (AF) are comorbid conditions that are increasingly prevalent and have a high socioeconomic burden. This article discusses their shared pathophysiology, focusing on the triad of hypertension, obesity, and aging.We
American College of Cardiology
JANUARY 8, 2024
Obesity is a multifaceted disease that is directly and indirectly implicated in atherosclerotic cardiovascular disease (CVD), heart failure (HF), atrial fibrillation (AF), and multiple CVD risk factors, including dyslipidemia, hypertension, type 2 diabetes mellitus (DM), and sleep disorders.
70 
Journal of the American Heart Association
MARCH 21, 2025
BackgroundThe clinical utility of the polygenic risk score in predicting cardiovascular events in patients with atrial fibrillation (AF) has not yet been established. years), the incidence rates of ischemic stroke or systemic embolism, myocardial infarction, and heart failure hospitalization were 0.83, 0.42, and 0.61
Journal of the American Heart Association
FEBRUARY 26, 2025
Journal of the American Heart Association, Ahead of Print. BackgroundMultimorbidity is common among patients with atrial fibrillation (AF) and is associated with worse outcomes. AF symptom severity was assessed via the University of Toronto AF Severity Scale questionnaire.
Circulation
JUNE 4, 2024
We projected through 2050, overall and by age and race and ethnicity, accounting for changes in disease prevalence and demographics.RESULTS:We estimate that among adults, prevalence of hypertension will increase from 51.2% to 9.2%), heart failure (2.7% to 6.4%), atrial fibrillation (1.7% in 2020 to 61.0%
81 
Open Heart
JUNE 1, 2022
Objectives We aim to assess the association of cardiovascular medications with outcomes of patients referred to the diagnostic heart failure (HF) clinic with symptoms or signs of possible HF, raised N-terminal pro-brain-type natriuretic peptide (NT-proBNP) but no evidence of HF on transthoracic echocardiography (TTE). to 0.97; p=0.02).
HeartRhythm
MARCH 12, 2024
1 Atrial fibrillation (AF) is the most common cardiac arrhythmia, affecting more than 6 million individuals in the United States.2 2 As noted elsewhere,3 DM and AF affect a population that shares concomitant conditions such as obesity, hypertension and even heart failure (HF). of the population.1
DAIC
FEBRUARY 18, 2025
Studies estimate that severe regurgitation occurs in up to 4% of individuals 75 and older and is often linked with conditions like heart failure, atrial fibrillation or pulmonary hypertension.
52 
Heart BMJ
DECEMBER 20, 2023
Hypertension is the single most important risk factor for development of atrial fibrillation (AF), which may be considered as a cardiac manifestation of hypertensive target organ damage. Furthermore, coexistence of hypertension and AF mutually amplifies the risk of complications, such as heart failure and stroke.
Circulation
JUNE 4, 2024
The human capital approach was used to estimate productivity losses from morbidity and premature mortality due to cardiovascular conditions.RESULTS:One in 3 US adults received care for a cardiovascular risk factor or condition in 2020.
HeartRhythm
FEBRUARY 26, 2024
Back in the early 1990s, it was generally believed that the transition from paroxysmal to permanent AF was due to aging and/or the effect of an underlying cardiovascular disease such as hypertension, valvular defects, or heart failure.
Journal of the American Heart Association
DECEMBER 29, 2023
ABSTRACTAtrial fibrillation (AF) is the most common cardiac arrhythmia. AF increases the risk of stroke, heart failure, dementia, and hospitalization. Obesity significantly increases AF risk, both directly and indirectly, through related conditions, like hypertension, diabetes, and heart failure.
45 Journal of Cardiovascular Electrophysiology
MARCH 10, 2025
ABSTRACT Background Aging of the population has resulted in more patients living with atrial fibrillation (AF) and age-related macular degeneration (AMD). years, p <0.0001), and had higher rates of hypertension (50.0% vs. 44.0%, p <0.0001), renal failure (1.7% vs. 3.1%, p <0.0001), and heart failure (27.3%
Circulation: Heart Failure
MARCH 8, 2024
Circulation: Heart Failure, Ahead of Print. Background:Current prevalence estimates of heart failure (HF) are primarily based on self-report or HF hospitalizations. Overt cardiovascular disease, which ranged from 2.1% (HF) to 13.6% (atrial fibrillation), was less common. were female, 25.6% were Black, 12.8%
Circulation
NOVEMBER 11, 2024
Introduction:Anticoagulation (AC) is the mainstay of thromboprophylaxis for stroke prevention in atrial fibrillation (AF) and is recommended. PSM components were age, gender, race, PPI use, anti-platelets, hypertension, coronary artery disease, heart failure, COPD, and CKD.
Frontiers in Cardiovascular Medicine
FEBRUARY 14, 2024
Specifically, this genetic factor was found to lower the risk of type 2 diabetes by 46.5%, coronary heart disease by 37.5%, ischemic stroke by 35.4%, cardiac-related mortality by 28.6%, heart failure by 28.2%, transient ischemic attack by 24%, atrial fibrillation by 15.2%, peripheral artery disease by 0.3%, and hypertension by 0.3%.
49 
Open Heart
NOVEMBER 14, 2023
Survival curves were performed among hospitalised patients with acute myocardial infarction (AMI) as well as heart failure. The most common comorbidities prior to OHCA were hypertension (43.6%), heart failure (23.6%), chronic ischaemic heart disease (23.6%) and atrial fibrillation (22.0%).
ADN Center of Excellence
SEPTEMBER 2, 2024
September is National Atrial Fibrillation (AFib) Awareness Month, a time dedicated to raising awareness about one of the most common yet often misunderstood heart conditions. Understanding Atrial Fibrillation Atrial Fibrillation is characterized by an irregular and often rapid heart rhythm that can lead to poor blood flow.
59 Heart BMJ
MAY 10, 2024
Arrhythmias, and in particular atrial fibrillation (AF), are one of the greatest healthcare challenges of our time. Hospitalisation due to this condition is exponentially growing, and now outnumbers those for both heart failure and myocardial infarction.
40 
Stroke Journal
JANUARY 30, 2025
AI-ECG prediction models developed at our institution can evaluate the probability of atrial fibrillation (AF) and estimate a patients age based on a normal sinus rhythm (NSR) ECG. Migraine with aura(MwA) is associated with an increased risk of stroke and adverse vascular outcomes compared to those with migraine without aura (MwoA).
HeartRhythm
JANUARY 24, 2024
In the last 30 years, the major scientific societies have provided proper guidelines to ease and make more effective the management of patients with a variety of clinical conditions including acute coronary syndromes, hypertension, heart failure and atrial fibrillation.
Stroke Journal
JANUARY 30, 2025
Background:The STRACK project aims to improve post-stroke patient management and the transition from acute to primary care thanks to improvements in patient pathways and monitoring cardiovascular risk factors: heart failure, diabetes, atrial fibrillation, dyslipidemia and hypertension.
40 
ADN Center of Excellence
SEPTEMBER 2, 2024
September is National Atrial Fibrillation (AFib) Awareness Month, a time dedicated to raising awareness about one of the most common yet often misunderstood heart conditions. Understanding Atrial Fibrillation Atrial Fibrillation is characterized by an irregular and often rapid heart rhythm that can lead to poor blood flow.
52 
DAIC
FEBRUARY 29, 2024
24 will focus on the following three current guideline updates: American College of Cardiology (ACC)/American Heart Association (AHA) Guidelines 2023 Atrial Fibrillation Guideline - Pharmacology II: Strokes vs. Bleeds, What Do the Guidelines Tell Us About Practical Management in A-fib? The Guidelines Sessions at ACC.24
103 Stroke Journal
JANUARY 30, 2025
Propensity score-matched analysis (PSM) (1:1) was performed with matching for age, gender, race, BMI, hypertension, diabetes mellitus, chronic kidney disease, hemoglobin level, low-density lipid (LDL) level, left ventricular ejection fraction, and various drugs including ACEi, ARBi, ARNI, beta-blockers, and diuretics. years, with 49.27% men.
40 Journal of the American Heart Association
MARCH 27, 2025
Six multimorbidity patterns were identified, including 4 specific patterns: (1) pattern 1, cerebrovascular cluster (histories of cerebrovascular disease and hypertension); (2) pattern 2, traditional cardiovascular disease risk factors cluster (histories of hyperlipidemia, obesity, anddiabetes, and family history of cardiovascular disease and smoking); (..)
Journal of Cardiovascular Electrophysiology
FEBRUARY 19, 2025
Renal sympathetic denervation not only has been shown to ameliorate the treatment of patients with hypertension, but may also reduce atrial and ventricular arrhythmias. Patients with heart failure may be improved clinically by potentiating parasympathetic tone.
DAIC
JUNE 18, 2024
High Blood Pressure Rising Because high blood pressure, also known as hypertension, contributes to nearly all types of heart disease and stroke, researchers made separate predictions for this condition. According to their projections, from 2020 to 2050, high blood pressure is expected to rise from 51.2% to 61% of the U.S.
105 
European Journal of Heart Failure
SEPTEMBER 15, 2023
Aims Patients with heart failure usually have several other medical conditions that might alter the effects of interventions. A prior history of the following comorbidities was considered: episodic or persistent atrial fibrillation ( n = 920), coronary artery disease ( n = 3732), diabetes ( n = 2171), and hypertension ( n = 3353).
Stroke: Vascular and Interventional Neurology
NOVEMBER 9, 2023
Baseline patient demographics and clinical characteristics recorded include age, gender, HbA1C level, National Institutes of Health Stroke Scale (NIHSS) at admission, manual CT ASPECTS and stroke risk factors (hypertension, atrial fibrillation, coronary artery disease, congestive heart failure, LDL, smoking, history of stroke/TIAs).
40 Stroke Journal
FEBRUARY 1, 2024
Compared to White, black and Hispanic had higher rate of Diabetes, Hypertension and prior stroke (p<0.001). The rates of other risk factors (hyperlipidemia, smoking, illicit drug use, chronic heart failure, coronary artery disease, and atrial fibrillation) did not vary by race.
40 
DAIC
DECEMBER 19, 2023
OSA disproportionately affects the 92 million Americans living with cardiovascular disease (CVD), often goes undiagnosed (1) , and doubles the risk for heart failure and other serious cardiovascular conditions. Studies estimated that identifying and treating every patient in the U.S. billion (2). David's Medical Center.
Stroke Journal
FEBRUARY 1, 2024
VRFs included hypertension, dyslipidemia, obesity, smoking, atrial fibrillation, coronary artery disease, heart failure, diabetes, and sleep apnea. Patients aged 18-55 with a diagnosis of IS were included and separated into two age groups: 18-35 and 36-55.
40 
Stroke: Vascular and Interventional Neurology
NOVEMBER 9, 2023
The patient underwent surgery, but suffered from a gastrointestinal bleed and developed post‐operative atrial fibrillation; after a risks/benefits discussion, he was discharged on anticoagulation only. Findings were most consistent with rotational occlusion of the left vertebral artery, which is also known as BHS.
40 
All About Cardiovascular System and Disorders
APRIL 14, 2024
Echocardiographic assessment of left ventricular diastolic function with special reference on diastolic function assessment in atrial fibrillation. One situation is decompensated advanced systolic heart failure with large left ventricle. There are also limitations for E/E’ in the assessment of LV diastolic dysfunction.
All About Cardiovascular System and Disorders
APRIL 30, 2024
Left ventricular hypertrophy, left atrial enlargement, QRS axis deviation (left more than right), conduction abnormalities like increased P-R interval and bundle branch block may be noted. in hypertensives are some of the features. Athlete’s heart is another entity with hypertrophy which may be confused with HCM.
Dr. Smith's ECG Blog
NOVEMBER 19, 2016
It was edited by Smith CASE : A 52-year-old male with a past medical history of hypertension and COPD summoned EMS with complaints of chest pain, weakness and nausea. In cardiogenic shock, fluid may worsen the pulmonary edema associated with acute heart failure, but may still be required to support the hemodynamic status of the patient.
40
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content